Stress disturbs homeostasis by altering the equilibrium of various hormones which have a significant impact on immune responses. Few studies have examined the influence of stressors on autoimmune disease in animal models. In our work, we studied the effects of long-term exposure (14 days) to chronic varied stress (CVS) in a model of experimental autoimmune encephalomyelitis (EAE) in Wistar rats. We studied whether the exposure to CVS before or after the immune challenge would correlate with differences in the clinical course of the disease. We also examined whether the CVS would modulate the magnitude of the cellular or the humoral immune response. We observed opposite effects on the clinical signs in animals stressed before or after the immune challenge. The clinical signs of the disease were attenuated in animals stressed before but not after the immune challenge. Relationships were found in the modulation of the clinical severity related to the time of exposure to the CVS, the histological alterations and the proliferative results. Stressed animals with milder clinical signs presented an exacerbated humoral response against myelin antigens while stressed animals with more severe clinical symptoms exhibited a significantly diminished one. Besides, we detected the presence of specific IgG1 associated with the exposure to CVS before the induction of EAE. Our results show that, depending on the timing of the exposure of Wistar rats to the CVS, the neuroendocrine disbalance favors a more pronounced humoral or cellular profile of the response.
INTRODUCTION
Stress disturbs homeostasis by altering the equilibrium of various hormones having a significant impact on immune responses in general (Black, 1994; Khansari et al., 1990; Ader et al., 1995) . Many clinical reports associate different life event stressors with lowered immunity (Maier et al., 1994; Chrousos, 1995) . The influences of stressors on immune responses are complex and depend upon the nature, intensity and chronicity of the particular stressor(s) involved (Moynihan et al., 1994) . Not only the characteristics but the time at which the stressor is applied in relation to the course of the immune response could determine the effects. Stress-induced immunomodulation is mediated, in part, through products of the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis (Khansari et al., 1990; Ader & Cohen, 1993; Savino & Dardenne, 1995) . The importance of the SNS and the HPA axis in the development or recovery of autoimmune diseases has also been outlined (Levine et al., 1986; Chelmicka-Schorr et al., 1988; MacPhee et al., 1989; Harbuz 
